Patients with prior thrombosis, thrombophilia, or cancer require individualized risk assessment and may benefit from additional monitoring or alternative therapy
Its distinct mode of action keeps drawing a lot of attention for additional study
Additionally, case reports and prospective cohort studies of patients treated with GLP-1 RAs have demonstrated reductions in the Psoriasis Area and Severity Index (PASI) score, Physicians Global Assessment (PGA), and Dermatology Life Quality Index (DLQI) after 212 months of treatment [11,12,13,14,15,16]
In this blog, well break down the role of these medications, explore their pros and cons, and help you understand if they might be a good option for you